Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
INVIVYD via FORBES-TATE
2026 · third_quarter · Q3
Issues related to infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2026 · third_quarter · Q3
Source: Senate LDA
| AUBURN UNIVERSITY |
| 32 |
| 2012–2020 |
| VIRPAX PHARMACEUTICALS | 31 | 2019–2026 |
| GENENTECH | 30 | 2019–2026 |
| NATIONAL ASSOCIATION OF PROTON THERAPY | 29 | 2019–2026 |
| ALEXION PHARMACEUTICALS, INC. | 28 | 2020–2026 |
| GRAIL, Inc. | 27 | 2020–2026 |
| SANOFI U.S. | 26 | 2019–2025 |
| BIO-RAD LABORATORIES | 23 | 2020–2025 |
| DIRECT SUPPLY INC | 22 | 2021–2026 |
| ALABAMA DISTRICT ATTORNEYS ASSOCIATION | 21 | 2016–2020 |
| ANHEUSER-BUSCH COMPANIES, INC. | 21 | 2013–2020 |
| EMERGENT BIOSOLUTIONS | 20 | 2019–2023 |
| IRON MOUNTAIN INFORMATION MANAGEMENT, LLC | 20 | 2017–2022 |
| VIR BIOTECHNOLOGY, INC. | 20 | 2020–2024 |
| LUNDBECK LLC | 18 | 2017–2021 |
| SAREPTA THERAPEUTICS | 18 | 2018–2022 |
| Sorrento Therapeutics, Inc. | 18 | 2017–2021 |
| A PLACE FOR MOM, INC. | 17 | 2018–2022 |
| BAYER CORPORATION | 17 | 2019–2022 |
| PINE STREET STRATEGIES ON BEHALF OF THE CITY OF BIRMINGHAM, ALABAMA | 17 | 2018–2021 |
| GINKGO BIOWORKS | 15 | 2020–2023 |
| MILANAPHARM | 14 | 2019–2022 |
| VERDE TECHNOLOGIES | 14 | 2019–2022 |
| AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION | 13 | 2023–2026 |
| CITY OF BIRMINGHAM, ALABAMA | 13 | 2023–2026 |
| EYEPOINT PHARMACEUTICALS, INC. | 13 | 2020–2022 |
| GILEAD SCIENCES, INC. | 13 | 2020–2022 |
| THE PARTNERSHIP FOR AMERICAS HEALTH CARE FUTURE | 12 | 2019–2021 |
| ALLERGAN USA, INC. | 11 | 2013–2015 |
| METRC LLC | 11 | 2019–2021 |
| NOVARTIS, INC. | 11 | 2019–2021 |
| ABBOTT LABORATORIES | 10 | 2016–2020 |
| ADAPT PHARMA INC. | 10 | 2016–2018 |
| HALOZYME THERAPEUTICS, INC. | 10 | 2019–2021 |
| ICE MILLER LLP ON BEHALF OF CITY OF BIRMINGHAM ALABAMA | 10 | 2021–2023 |
| SAVING AMERICAS FAMILY ENTERPRISES, INC. | 10 | 2021–2023 |
| SCANA CORPORATION | 10 | 2013–2015 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF AMAZON.COM | 9 | 2012–2014 |
| PRISM GROUP PUBLIC AFFAIRS ON BEHALF OF PIEDMONT HEALTHCARE | 9 | 2020–2022 |
| STANDARD INDUSTRIES, INC. | 9 | 2020–2021 |
| DIGESTIVE HEALTH PHYSICIANS ASSOCIATION | 8 | 2025–2026 |
| UNITEDHEALTH GROUP | 8 | 2013–2015 |
| ARGENTUM | 7 | 2022–2023 |
| CISCO SYSTEMS, INC. | 7 | 2013–2014 |
| EVOLUS BEAUTY | 7 | 2019–2020 |
| MOLINA HEALTHCARE, INC. | 7 | 2020–2021 |
| PELOTON INTERACTIVE, INC. | 7 | 2021–2022 |
| AEON BIOPHARMA | 6 | 2019–2020 |
| CITY OF OPELIKA, ALABAMA | 6 | 2016–2017 |
| ARCTURUS THERAPEUTICS | 5 | 2020–2021 |
| ASC ADVOCACY COMMITTEE | 5 | 2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF ALLERGAN USA, INC. | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF ASC ADVOCACY COMMITTEE | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF CTIA THE WIRELESS ASSOCIATION | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF HCR MANORCARE | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF NORTHPORT HEALTH SERVICES | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF NORTHWESTERN ENERGY | 5 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF UNITEDHEALTH GROUP, INC. | 5 | 2012–2013 |
| INVIVYD | 5 | 2025–2026 |
| VIZGEN INC | 5 | 2025 |
| ADVANCED MEDICAL TECHNOLOGY ASSOCIATION | 4 | 2013–2014 |
| BELLEROPHON THERAPEUTICS | 4 | 2020 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF ANHEUSER-BUSCH | 4 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF EDWARDS LIFESCIENCES, LLC | 4 | 2012–2013 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF KABA MAS | 4 | 2012–2013 |
| CTIA - THE WIRELESSS ASSOCIATION | 4 | 2013–2014 |
| EUSA PHARMA LLC | 4 | 2020 |
| KIMBELL & ASSOCIATES ON BEHALF OF HEARTWARE | 4 | 2014 |
| NORTHWESTERN ENERGY | 4 | 2013–2014 |
| PILL CLUB HOLDINGS, INC. | 4 | 2019–2020 |
| SPERO THERAPEUTICS, INC. | 4 | 2021–2022 |
| U.S. ANESTHESIA PARTNERS, INC. | 4 | 2023 |
| UBER TECHNOLOGIES INC. | 4 | 2020 |
| UNITED MUSCULOSKELETAL PARTNERS, LLC | 4 | 2023 |
| US Radiology Specialists, Inc. | 4 | 2023 |
| HD NURSING | 3 | 2023 |
| KAHALA BIOSCIENCES | 3 | 2020 |
| MERCK | 3 | 2013–2014 |
| OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL | 3 | 2025 |
| PRIVAPATH DIAGNOSTICS, INC. DBA LET'S GET CHECKED, INC. | 3 | 2020 |
| SUPERFILE, INC. | 3 | 2026 |
| SYNDAX PHARMACEUTICALS | 3 | 2020 |
| VERIZON COMMUNICATIONS INC AND VARIOUS SUBSIDIARIES | 3 | 2013–2014 |
| ABYRX, INC. | 2 | 2020 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF AMERICAN SPORTFISHING ASSOCIATION | 2 | 2012 |
| INDEPENDENT PHARMACY COOPERATIVE | 2 | 2016 |
| ULTRAGENYX PHARMACEUTICAL | 2 | 2020 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF MERCK | 1 | 2012 |
| CAUTHEN FORBES & WILLIAMS ON BEHALF OF ORACLE | 1 | 2013 |
| INTERNATIONAL COUNCIL OF SHOPPING CENTERS | 1 | 2022 |
| LILLY USA, LLC | 1 | 2020 |
| SURESCRIPTS | 1 | 2019 |
| TENNESSEE RURAL HEALTH IMPROVEMENT ASSOCIATION | 1 | 2021 |
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in H.R. 1 - One Big Beautiful Bill Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Doctor Knows Best Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
ROCR Value Based Program Act
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Radiology Outpatient Ordering Transmission (ROOT) Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Bipartisan Health Care Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 2474 - Strengthening Medicare for Patients and Providers Act; Issues related to H.R. 6371 - Provider Reimbursement Stability Act of 2023; Issues related to S. 4935 - Physician Fee Stabilization Act.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to H.R 5539/S. 3131 - the ORPHAN Cures Act.
Provider Reimbursement Stability Act of 2023
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 2474 - Strengthening Medicare for Patients and Providers Act; Issues related to H.R. 6371 - Provider Reimbursement Stability Act of 2023; Issues related to S. 4935 - Physician Fee Stabilization Act.
Improving Seniors’ Timely Access to Care Act of 2024
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act of 2024.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to H.R 5539/S. 3131 - the ORPHAN Cures Act.
Improving Seniors’ Timely Access to Care Act of 2024
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act of 2024.
Physician Fee Stabilization Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 2474 - Strengthening Medicare for Patients and Providers Act; Issues related to H.R. 6371 - Provider Reimbursement Stability Act of 2023; Issues related to S. 4935 - Physician Fee Stabilization Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Strengthening Medicare for Patients and Providers Act
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: CITY OF BIRMINGHAM, ALABAMA · Firm: FORBES-TATE
Issues regarding FY24 Appropriations; Issues related to Transportation-HUD, H.R. 4820/S. 2437 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: CITY OF BIRMINGHAM, ALABAMA · Firm: FORBES-TATE
Issues regarding FY24 Appropriations; Issues related to Transportation-HUD, H.R. 4820/S. 2437 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024.
Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024
Client: CITY OF BIRMINGHAM, ALABAMA · Firm: FORBES-TATE
Issues regarding FY24 Appropriations; Issues related to Transportation-HUD, H.R.4820/S. 2437 - Transportation, Housing and Urban Development, and Related Agencies Appropriations Act, 2024.
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: NATIONAL ASSOCIATION OF PROTON THERAPY · Firm: FORBES-TATE
Issues regarding access to proton therapy; including in H.R.5894/S.2624 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2024.
Provider Reimbursement Stability Act of 2023
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Provider Reimbursement Stability Act of 2023
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Provider Reimbursement Stability Act of 2023
Client: AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION · Firm: FORBES-TATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; H.R. 2474 - Strengthening Medicare for Patients and Providers Act; H.R. 6371 - Provider Reimbursement Stability Act of 2023; S. 4935 - Physician Fee Stabilization Act.
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERFILE, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to encryption.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2026 · third_quarter · Q3
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to intellectual property and process patent.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues related to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2026 · third_quarter · Q3
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · third_quarter · Q3
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2026 · third_quarter · Q3
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
2026 · third_quarter · Q3
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECT SUPPLY, INC. via FORBES-TATE
2026 · third_quarter · Q3
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · third_quarter · Q3
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
INVIVYD via FORBES-TATE
2026 · second_quarter · Q2
Issues related to infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2026 · second_quarter · Q2
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2026 · second_quarter · Q2
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Q2
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SUPERFILE, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to encryption.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · second_quarter · Q2
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
DIRECT SUPPLY, INC. via FORBES-TATE
2026 · second_quarter · Q2
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · second_quarter · Q2
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2026 · second_quarter · Q2
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the forthcoming CY 2027 Physician Fee Schedule Proposed Rule regarding possible establishment of a national reimbursement structure for proton beam therapy treatment.
Issues pertaining to veterans' access to proton therapy.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
GENENTECH via FORBES-TATE
2026 · second_quarter · Q2
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Intellectual property and process patent related issues.
SUPERFILE, INC. via FORBES-TATE
2026 · second_quarter · RR
Issues related to IT security.
INVIVYD via FORBES-TATE
2026 · first_quarter · Q1
Issues related to infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2026 · first_quarter · Q1
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2026 · first_quarter · Q1
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
Issues pertaining to veterans' access to proton therapy.
2026 · first_quarter · Q1
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the 340B Drug Pricing Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECT SUPPLY, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to Medicare Advantage; Issues related to physician payments.
Issues related to healthcare data; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2026 · first_quarter · Q1
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
AMGEN USA, INC. via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2026 · first_quarter · Q1
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44); Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
2025 · fourth_quarter · Q4
Issues related to NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Q4
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECT SUPPLY, INC. via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2025 · fourth_quarter · Q4
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (PL 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2025 · fourth_quarter · Q4
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; Issues related to the CY 2026 Physician Fee Schedule Final Rule regarding reimbursement for proton beam therapy treatment.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2026 Labor-HHS appropriations process.
AMGEN USA, INC. via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
INVIVYD via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to infectious diseases.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to athlete visas.
Issues related to taxation.
Issues related to ticketing.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to H.R. 5737/S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2025 · fourth_quarter · Q4
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2025 · fourth_quarter · Q4
Intellectual property and process patent related issues.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
INVIVYD via FORBES-TATE
2025 · fourth_quarter · RR
Issues related to infectious diseases.
AMGEN USA, INC. via FORBES-TATE
2025 · third_quarter · Q3
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2025 · third_quarter · Q3
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2025 · third_quarter · Q3
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2025 · third_quarter · Q3
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIO-RAD LABORATORIES via FORBES-TATE
2025 · third_quarter · Q3
Issues related to biomedical research and development; Issues related to pathogen surveillance.
Issues related to biomedical research and development; Issues related to pathogen surveillance.
Issues related to advanced diagnostic testing and laboratory tools.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2025 · third_quarter · Q3
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
2025 · third_quarter · Q3
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2025 · third_quarter · Q3
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (P.L. 89-73), intergenerational therapy; Issues related to Medicare requirements for participation.
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2025 · third_quarter · Q3
Issues pertaining to veterans' access to proton therapy.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; Issues related to H.R. 2120/S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2025 · third_quarter · Q3
Issues related to athlete visas.
Issues related to taxation.
Issues related to ticketing.
DIRECT SUPPLY, INC. via FORBES-TATE
2025 · third_quarter · Q3
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2025 · third_quarter · Q3
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Q3
Issues related to NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2025 · third_quarter · Q3
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2025 · third_quarter · Q3
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENENTECH via FORBES-TATE
2025 · third_quarter · Q3
Intellectual property and process patent related issues.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
OFFICE OF THE COMMISSIONER OF BASEBALL D/B/A MAJOR LEAGUE BASEBALL via FORBES-TATE
2025 · fourth_quarter · RR
Issues related to taxation (TAX), broadcasting of games (COM), stadium airspace (HOM, AVI), and athlete visas (LBR).
Issues related to taxation (TAX), broadcasting of games (COM), stadium airspace (HOM, AVI), and athlete visas (LBR).
Issues related to taxation (TAX), broadcasting of games (COM), stadium airspace (HOM, AVI), and athlete visas (LBR).
2025 · second_quarter · Q2
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIRECT SUPPLY, INC. via FORBES-TATE
2025 · second_quarter · Q2
Issues related to senior care.
Issues related to senior care.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2025 · second_quarter · Q2
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to Medicare physician fee schedule.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2025 · second_quarter · Q2
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
BIO-RAD LABORATORIES via FORBES-TATE
2025 · second_quarter · Q2
Issues related to biomedical research and development; Issues related to pathogen surveillance.
Issues related to biomedical research and development; Issues related to pathogen surveillance.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VIRPAX PHARMACEUTICALS via FORBES-TATE
2025 · second_quarter · Q2
Issues related to the opioid crisis.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2025 · second_quarter · Q2
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (PL 116-260); Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
STRATHSPEY CROWN HOLDINGS, LLC via FORBES-TATE
2025 · second_quarter · Q2
Issues related to CMS coverage decisions and issues related to healthcare reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2025 · second_quarter · Q2
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to orphan drugs under the Drug Price Negotiation Program.
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2025 · second_quarter · Q2
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF PROTON THERAPY via FORBES-TATE
2025 · second_quarter · Q2
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
Issues related to the reimbursement in Medicare and Medicaid for providers of proton beam therapy; issues related to S. 1031 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act; issues related to H.R. 2120 - Radiation Oncology Case Rate (ROCR) Value-Based Program Act.
2025 · second_quarter · Q2
Issues related to NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NORTHPORT HEALTH SERVICES via FORBES-TATE
2025 · second_quarter · Q2
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, post-acute care reform, the Older Americans Act (P.L. 89-73), intergenerational therapy; issues related to Medicare requirements for participation.
Healthcare legislative issues, including Medicare, Medicaid, and budget issues; Issues related to nursing home arbitration, group and concurrent therapy, and post-acute care reform.
GENENTECH via FORBES-TATE
2025 · second_quarter · Q2
Intellectual property and process patent related issues.
Issues related to Medicare and Medicaid coverage and reimbursement; Issues pertaining to 340B; Issues related to drug importation; Issues related to prescription drug pricing; Issues related to the International Pricing Index for Medicare Part D; Issues related to prescription drug user fee agreement; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to pharmacy benefit managers; Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2025 · second_quarter · Q2
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMGEN USA, INC. via FORBES-TATE
2025 · first_quarter · Q1
Issues related to the implementation of international tax and tax reform in the Tax Cuts and Jobs Act (PL 115-97); Issues related to Puerto Rico tax; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
AMERICAN COLLEGE OF RADIOLOGY ASSOCIATION via FORBES-TATE
2025 · first_quarter · Q1
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act.
AMERICAN INDEPENDENT MEDICAL PRACTICE ASSOCIATION via FORBES-TATE
2025 · first_quarter · Q1
Issues related to healthcare; Issues related to provider reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALEXION PHARMACEUTICALS, INC. via FORBES-TATE
2025 · first_quarter · Q1
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to the Inflation Reduction Act of 2022 (PL 117-169).
Issues related to healthcare, including drug pricing and Medicare Part D; Issues related to low-volume Diagnosis Related Groups (DRG); Issues related to orphan drug tax credit; Issues related to rare disease; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to H.R 5539/S. 3131 - the ORPHAN Cures Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Q1
Issues related to NIH Funding.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DIGESTIVE HEALTH PHYSICIANS ASSOCIATION via FORBES-TATE
2025 · first_quarter · Q1
Issues related to healthcare data; Issues related to provider reimbursement.
Issues related to Medicare Advantage; Issues related to physician payments.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CITY OF BIRMINGHAM, ALABAMA via FORBES-TATE
2025 · first_quarter · Q1
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
FY25/26 Appropriations - Homeland/FEMA, CJS, THUD, E&W; Issues related to crime; Issues related to transportation infrastructure; Issues related to flood mitigation; Issues related to waterways infrastructure; Issues related to economic development; Issues related to housing.
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to SUPPORT for Patients and Communities Reauthorization Act of 2025 (PL 119-44).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2027 Labor-HHS appropriations process.
Issues pertaining to veterans' access to proton therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2027 Labor-HHS appropriations process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to international tax and R&D amortization credit in the Tax Cuts and Jobs Act (PL 115-97); Issues related to tax; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2027 Labor-HHS appropriations process.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Intellectual property and process patent related issues.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues pertaining to veterans' access to proton therapy.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to broadcasting of games.
Issues related to stadium airspace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to Medicare physician fee schedule.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to the 340B Drug Pricing Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (PL 116-260); Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to Medicare physician fee schedule.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid.
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in the One Big Beautiful Bill Act (PL 119-21).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to continued access to and provider reimbursement for proton beam therapy; Issues related to the Fiscal Year 2026 Labor-HHS appropriations process.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Issues related to broadcasting of games.
Issues related to stadium airspace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to taxation (TAX), broadcasting of games (COM), stadium airspace (HOM, AVI), and athlete visas (LBR).
Issues related to taxation (TAX), broadcasting of games (COM), stadium airspace (HOM, AVI), and athlete visas (LBR).
Issues related to the Medicare Physician Fee Schedule and Authorized Use Criteria (AUC) in H.R. 1 - One Big Beautiful Bill Act.
Issues related to Medicare and Medicaid payments to physicians; Issues related to medical imaging; Issues related to Appropriate Use Criteria (AUC); Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 639 - Doctor Knows Best Act of 2025; Issues related to H.R. 879/S. 1640 - Medicare Patient Access and Practice Stabilization Act of 2025; Issues related to S. 891 - Bipartisan Health Care Act; Issues related to S. 1692 - Radiology Outpatient Ordering Transmission (ROOT) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to prescription drug pricing; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to continued access to and provider reimbursement for proton beam therapy; issues related to the Fiscal Year 2026 Labor-HHS appropriations process.
Issues pertaining to veterans' access to proton therapy.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding the Center for Medicare and Medicaid Innovation; Issues related to the implementation of the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Issues related to funding of the strategic national stockpile; Issues related to the Tax Cuts and Jobs Act (PL 115-97); Issues related to the Medicaid Drug Rebate Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to Biosimilars; Issues related to drug pricing; Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Issues regarding implementation of the Consolidated Appropriations Act, 2021 (PL 116-260); Issues related to the Inflation Reduction Act of 2022 (PL 117-169); Issues related to the Medicaid Drug Rebate Program; Issues related to the 340b program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues related to proposed cuts in the CY 2025 Medicare Physician Fee Schedule proposed rule; Issues related to H.R. 2474 - Strengthening Medicare for Patients and Providers Act; Issues related to H.R. 6371 - Provider Reimbursement Stability Act of 2023; Issues related to S. 4935 - Physician Fee Stabilization Act.
Issues related to surprise billing; Issues related to prior authorization in Medicare and Medicaid; Issues related to H.R. 8702/S. 4532 - Improving Seniors Timely Access to Care Act of 2024.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE